Double-blind, placebo-controlled study of botulinum toxin injections in the treatment of cervical dystonia
- PMID: 7606182
Double-blind, placebo-controlled study of botulinum toxin injections in the treatment of cervical dystonia
Abstract
Botulinum toxin injections were given to 23 patients with cervical dystonia in a double-blind, placebo-controlled, crossover study. Each patient was randomly given 100 units of botulinum A toxin and placebo in two respective sets of injections into the two most active contracting neck muscles at least 3 months apart. Before and 3 weeks after each set of injections, the cervical dystonia was "blindly" scored by the investigator. Each patient was also asked to independently score the improvement of the dystonia and neck pain. Four patients dropped out and one patient showed spontaneous remission. The remaining 18 patients completed the study and showed a significant improvement after the injections of botulinum toxin in comparison with that of the placebo. The effect started about 1 week after injection and the maximal effect lasted about 11 weeks in patients with a satisfactory response. The neck pain was satisfactorily relieved in 9 of 10 patients affected. There were no significant side effects. Thus, botulinum toxin injection is effective in treating cervical dystonias; injection of a higher dose of botulinum toxin in a greater number of neck muscles is required for those patients with complex cervical dystonia.
Similar articles
-
Botulinum toxin A--injection for cervical dystonia.J Assoc Physicians India. 1999 Mar;47(3):267-70. J Assoc Physicians India. 1999. PMID: 10999117 Clinical Trial.
-
Botulinum toxin type B: a double-blind, placebo-controlled, safety and efficacy study in cervical dystonia.Neurology. 1997 Sep;49(3):701-7. doi: 10.1212/wnl.49.3.701. Neurology. 1997. PMID: 9305326 Clinical Trial.
-
Botulinum toxin in cervical dystonia.Adv Neurol. 1988;49:473-8. Adv Neurol. 1988. PMID: 3344637 No abstract available.
-
Use of botulinum toxin in the treatment of cervical dystonia.Baillieres Clin Neurol. 1993 Apr;2(1):179-85. Baillieres Clin Neurol. 1993. PMID: 8143072 Review.
-
Botulinum toxin B: a review of its therapeutic potential in the management of cervical dystonia.Drugs. 2002;62(4):705-22. doi: 10.2165/00003495-200262040-00011. Drugs. 2002. PMID: 11893235 Review.
Cited by
-
Clinical Practice: Evidence-Based Recommendations for the Treatment of Cervical Dystonia with Botulinum Toxin.Front Neurol. 2017 Feb 24;8:35. doi: 10.3389/fneur.2017.00035. eCollection 2017. Front Neurol. 2017. PMID: 28286494 Free PMC article. Review.
-
Botulinum toxin type A therapy for cervical dystonia.Cochrane Database Syst Rev. 2017 Dec 12;12(12):CD003633. doi: 10.1002/14651858.CD003633.pub3. Cochrane Database Syst Rev. 2017. Update in: Cochrane Database Syst Rev. 2020 Nov 12;11:CD003633. doi: 10.1002/14651858.CD003633.pub4. PMID: 29230798 Free PMC article. Updated.
-
The Comparative Study of the Effects of Botulinum Toxin Micro-droplet Injection Combined with Micro-crosslinked Sodium Hyaluronate Gel or Focused Ultrasound Technology in Facial Rejuvenation Treatment.Aesthetic Plast Surg. 2025 Jun 4. doi: 10.1007/s00266-025-04903-y. Online ahead of print. Aesthetic Plast Surg. 2025. PMID: 40464862
-
Patient education for neck pain.Cochrane Database Syst Rev. 2012 Mar 14;2012(3):CD005106. doi: 10.1002/14651858.CD005106.pub4. Cochrane Database Syst Rev. 2012. PMID: 22419306 Free PMC article.
-
Botulinum toxin type A therapy for cervical dystonia.Cochrane Database Syst Rev. 2020 Nov 12;11(11):CD003633. doi: 10.1002/14651858.CD003633.pub4. Cochrane Database Syst Rev. 2020. PMID: 33180963 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical